The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following definitive therapy. Part II - Rapid review of dietary supplements

Current Opinion in Urology

Volumn 13, Issue 2, 2003, Pages 147-151

  Moyad, Mark A ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Aspirin; Complementary medicine; Dietary supplements; Fish oil; Multivitamins; Prostate cancer; Selenium; Vitamin E

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; CYANOCOBALAMIN; FISH OIL; FOLIC ACID; MULTIVITAMIN; PYRIDOXINE; SELENIUM; VITAMIN D;

BLOOD LEVEL; CANCER GROWTH; CANCER RECURRENCE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET SUPPLEMENTATION; DIETARY INTAKE; HUMAN; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SMOKING;

ASPIRIN; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; HUMANS; MALE; PROSTATIC NEOPLASMS; SELENIUM; VITAMINS;

EID: 0037335235     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200303000-00010     Document Type: Review

References (45)

1. Bonow RO, Smaha LA, Smith SC, et al. The international burden of cardiovascular disease: responding to the emerging epidemic. Circulation 2002; 106:1602-1605.
2. World Heart Federation. Call to action. http://www.worldheart.org/introduction/call_to_action.html. [Accessed 20 August 2002].
3. World Health Organization. Mental health: new understanding, new hope [report]. Geneva: World Health Organization; 2001. pp. 144-149.
4. Michaud CM, Murray CJL, Bloom BR. Burden of disease: implications for future research. JAMA 2001; 285:535-539.
5. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global burden of disease study. Lancet 1997; 349:1269-1276.
6. Clark LC, Combs Jr GF, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996; 276:1957-1963.
7. Newschaffer CJ, Otani K, McDonald MK, Penberthy LT. Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort. J Natl Cancer Inst 2000; 92:613-621.
8. Senior K. Atherosclerosis gene increases susceptibility to prostate cancer. Lancet 2002; 360:928.
9. Neugut AI, Rosenberg DJ, Ahsan H, et al. Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomarkers Prev 1998; 7:869-873.
10. Peterson HI. Tumor angiogenesis inhibition by prostaglandin synthetase inhibitors. Anticancer Res 1986; 6:251.
11. Moyad MA. Emphasizing and promoting overall health and nontraditional treatments after a prostate cancer diagnosis. Semin Urol Oncol 1999; 7:119-124.
12. Moyad MA. Beyond prevalence: complementary and alternative medicine, radiation treatment, and breast and prostate cancer. J Brachytherapy Intl 2001; 17:237-254. This is one of the first reviews that examined lifestyle factors and supplements that may reduces the risk of side effects from radiation therapy. This review found that healthy dietary changes may reduces the risk of complications and most supplements have never been tested in humans during radiation treatment. Therefore, no supplements should be consumed during the time of radiation treatment until more research is completed.
13. Devere White RW, Hackman RM, Soares SE, et al. Effects of a mushroom mycelium extract on the treatment of prostate cancer. Urology 2002; 60:640-644. This study did not receive much media attention. However, it is one of the only studies to examine the effect of a popular supplement in men with prostate cancer. This study found that large intakes of a specific mushroom supplement had little effect by itself to lower PSA levels.
14. Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults. JAMA 2002; 287:3116-3126.
15. Willett WC. Diet and cancer: one view at the start of the millennium. Cancer Epidemiol Biomarkers Prev 2001; 10:3-8. This article is a comprehensive review of lifestyle and supplement changes for overall health. It emphasizes the need to focus on the risk of cardiovascular disease for most patients. It also suggests that multivitamins may have an important role for health in many individuals.
16. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998; 316:894-898.
17. Giovannucci E, Rimm EB, Ascherio A, et al. Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 1995; 87:265-273.
18. Giovannucci E, Stampfer MJ, Colditz GA, et al. Mulitivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 1998; 129:517-524.
19. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997; 337:670-676.
20. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338:777-783.
21. Willet WC, Stampfer MJ. Selenium and cancer. BMJ 1988; 297:573-574.
22. Combs Jr GF, Clark LC, Turnbull BW. An analysis of cancer prevention by selenium. Biofactors 2001; 14:153-159.
23. Duffield-Lillico AJ, Reid ME, Turnbull BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002; 11:630-639. This is a follow-up investigation of the randomized trial of selenium from the University of Arizona. Researchers found that selenium supplements may lower the risk of a variety of cancers if individuals have low baseline levels of plasma selenium. However, it also found an increase in cancer risk for those that took selenium and had a higher level of baseline plasma selenium.
24. Reid ME, Duffield-Lillico AJ, Garland L, et al. Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 2002; 11:1285-1291.
25. Clark LC, Dalkin B, Krongrad A, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 1998; 81:730-734.
26. Brooks JD, Metter EJ, Chan DW, et al. Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 2001; 166:2034-2038.
27. Moyad MA. Selenium and vitamin E supplements for prostate cancer: evidence or embellishment? Urology 2002; 59 (suppl 4A):9-19. This paper is a comprehensive review of all the data that supports and negates the use of vitamin E and selenium supplements for men with and without prostate cancer. This paper assists the clinician in terms of deciding who is the ideal candidate for these supplements, and it provides dietary sources of this vitamin and mineral.
28. Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998; 90:440-446.
29. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360:23-33.
30. Yusuf S. Two decades of progress in preventing vascular disease. Lancet 2002; 360:2-3.
31. Waters DD, Alderman EL, Hsia J, et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 2002; 288:2432-2440.
32. Moyad MA, Brumfield SK, Pienta KJ, Vitamin E, alpha- and gamma-tocopherol, and prostate cancer. Semin Urol Oncol 1999; 17:85-90.
33. Jiang Q, Christen S, Shigenaga MK, Ames BN. Gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 2001; 74:714-722.
34. Foley DJ, White LR. Dietary intake of antioxidants and risk of Alzheimer disease: food for thought. JAMA 2002; 287:3261-3263.
35. Engelhardt MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002; 287:3223-3229.
36. Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 2002; 287:3230-3237.
37. Moyad MA. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: Part I. Semin Urol Oncol 2001; 19:294-305.
38. Moyad MA. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: Part II. Semin Urol Oncol 2001; 19:306-316.
39. Roberts RO, Jacobson DJ, Girman CJ, et al. A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer. Mayo Clin Proc 2002; 77:219-225.
40. Moyad MA. The ABCs of nutrition and supplements for prostate cancer. Ann Arbor: JW Edwards Publishing; 2000.
41. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354:447-455.
42. Krauss RM, Eckel RH, Howard B, et al. AHA Dietary Guidelines: revision 2000. A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000; 102:2284-2299.
43. Chung BH, Mitchell SH, Zhang SS, Young CY. Effects of docosahexaenoic acid and eicosapentsenoic acid on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells. Carcinogenesis 2001; 22:1201-1206.
44. Terry P, Lichtenstein P, Feychting M, et al. Fatty fish consumption and risk of prostate cancer. Lancet 2001; 357:1764-1766.
45. Aronson WJ, Glapsy JA, Reddy ST, et al. Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer. Urology 2001; 58:283-288.